Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma
{{output}}
Patients with pancreatic adenocarcinoma have an increased propensity for diabetes. Recent studies suggest patients with diabetes and pancreatic adenocarcinoma treated with metformin have increased survival. This study was undertaken to determine whether metfor... ...